Hussain, Syed, Professor

Professor Syed Hussain

MBBS, MSc, MD, FRCP

Clinical Medicine, School of Medicine and Population Health

Professor and Consultant in Medical Oncology

syed.hussain@sheffield.ac.uk
+44 114 215 9682

Room 228, 2nd Floor, Broomcross Building, Weston Park Hospital

Full contact details

Professor Syed Hussain
Clinical Medicine, School of Medicine and Population Health
Room 228, 2nd Floor, Broomcross Building
Weston Park Hospital
Whitham Road
91ֱ��
S10 2SJ

Profile

For enquiries please contact - ClinMed-Operational@sheffield.ac.uk

Professor Hussain graduated from Dow Medical College Karachi in 1994. He completed his general medical professional training in UK. He did his Doctorate in Oncology from University of Birmingham. He completed his medical oncology training in Birmingham, United Kingdom and received his certification and specialist registration in medical oncology.

Professor Hussain is Professor and Honorary Consultant in Medical Oncology at the University of 91ֱ�� and 91ֱ�� Teaching Hospitals NHS Trust. His major areas of interest are management of urological cancers, clinical trials, early drug development and translational medicine. He has set up several clinical trials from early phase to late phase studies during his career. His work on organ preservation in bladder cancer moved all the way from an early phase I study (Hussain et al Annals of Oncology 2001) to phase II efficacy study (Hussain et al BJC 2004) that led to a Cancer Research UK funded study BC2001 trial that was reported in New England Journal of Medicine (James, Hussain, Hall et al April 2012). This study has now changed the standard of care for patients with muscle invasive bladder cancer opting for organ preservation treatment globally. He has tailored split dose cisplatin regimen that has led to expand the spectrum of patients receiving cisplatin-based chemotherapy in bladder cancer (Hussain et al BJC 2004). He is a principal investigator of several studies in urological cancers. He was chief investigator of a national randomised placebo-controlled phase II neo-adjuvant study (NEOBLADE) in muscle invasive bladder cancer. He has served as a chief investigator of various early phase clinical trials, and translational studies. He is a chief investigator of a first in human window of opportunity study (INVEST) investigating the role of intravesical/intratumoral atezolizumab in patients with bladder cancer undergoing curative cystectomy. This is sponsored by STH and funded by Roche. He is also chief investigator of an international window of opportunity trial SOGUG NEOWIN investigating the role of erdafitinib and cetrelimab in FGF mutant bladder cancer patients undergoing curative cystectomy. This is jointly led by Hussain (UK), with Andrea Necchi (Italy), Yohann Loriot (France) and Guillermo Velasco (Spain) as other co-chief investigators. This study is funded by Janssen. He has authored over 125 peer-reviewed publications including 4 book chapters in textbooks of oncology. His Google scholar H-index is 40 with over 9800 citations (April 2023). He has published in high impact journals including New England Journal of Medicine, Lancet, Lancet Oncology, JAMA, JAMA Oncology, Journal of Clinical Oncology, European Urology, Annals of Oncology, Nature Communications, Clinical Cancer Research, British Journal of Cancer. He has been an invited speaker to number of national and international meetings and have delivered over 110 invited lectures. He has secured funding from cancer charities, national funding bodies and industries of over £15 million.

Professor Hussain was the member of NCRI Bladder and Renal group and Chair of the NCRI- Advanced Bladder Cancer sub-group in his national role. Professor Hussain was the expert witness to NICE on successful technology appraisals of Atezolizumab (2017), Avelumab (2021) and Nivolumab in Bladder cancer (2022).

Research interests

My major areas of interest are management of urological cancers, clinical trials, early drug development and translational medicine. I have set up a large number of clinical trials from early phase to late phase studies during my career.

My work on organ preservation in bladder cancer moved all the way from an early phase I study (Hussain et al Annals of Oncology 2001), to phase II efficacy study (Hussain et al BJC 2004) that led to a Cancer Research UK funded study BC2001 trial that was reported in New England Journal of Medicine (James, Hussain, Hall et al April 2012).

This study has now changed the standard of care for patients with muscle invasive bladder cancer opting for organ preservation treatment. I am principal investigator of a number of studies in urological cancers.

I am chief investigator of a national randomised placebo-controlled phase II neo-adjuvant study in muscle invasive bladder cancer and have served as chief investigator of various early phase trials, and translational studies.

I have authored over 125 peer-reviewed publications including 4 book chapters in textbooks of oncology. My Google scholar H-index is 40 with over 9800 citations (April 2023). I have published in high impact journals including New England Journal of Medicine, Lancet, Lancet Oncology, JAMA, JAMA Oncology, Journal of Clinical Oncology, European Urology, Annals of Oncology, Nature Communications, Clinical Cancer Research, British Journal of Cancer. I have been an invited speaker at a number of national and international meetings and have delivered over 110 invited lectures. I have secured funding from cancer charities, national funding bodies and industries of over £15 million.

Current Projects

Setting up of clinical trials in bladder cancers.
Early phase studies in bladder cancer.
Development of panel of Biomarkers in bladder cancer.
Translational research linked to bladder cancer clinical trials.

Publications

Show: Featured publications All publications

Featured publications

This person does not have any publications available.

All publications

Journal articles

Conroy S, Jubber I, Noon AP, Rosario DJ, Griffin J, Morgan S, Hubbard R, Kennish S, Mitchell S, Venugopal S , Linton K et al (2024) . BJU International.
Loriot Y, Necchi A, Hussain SA & De Velasco Oria GA (2024) . Annals of Oncology, 35, S1163-S1164.
Azam F, Alharbi H, Alshangiti A, Zar Gul AR, Bukhari N, Ouda M, Anwar Hussain S & Ibnshamsah F (2024) . Cureus, 16(8), e66520.
Jackson-Spence F, Ackerman C, Jones R, Toms C, Jovaisaite A, Young M, Hussain S, Protheroe A, Birtle A, Chakraborti P , Huddart R et al (2024) . Urologic Oncology: Seminars and Original Investigations.
Crabb SJ, Hussain SA, Oughton JB, Swain J, Cairns DA, Collinson M, Ainsworth G, McCready D, Griffin J, Heath P , Quayle L et al (2024) . Journal of Clinical Oncology, 42(16_suppl), TPS4621-TPS4621.
Hussain SA, Loriot Y, de Velasco G & Necchi A (2024) . Journal of Clinical Oncology, 42(16_suppl), TPS4623-TPS4623.
Naqvi SAA, Saxena A, Faisal KS, Bibi A, Khan MA, Cobran EK, Hussain SA, Riaz IB, Bryce AH & Singh P (2024) . Journal of Clinical Oncology, 42(16_suppl), e16619-e16619.
Faisal KS, Raina A, Khakwani KZR, Bin Riaz Z, Shah VS, Cobran EK, Singh P, Hussain SA, Bryce AH & Bin Riaz I (2024) . Journal of Clinical Oncology, 42(16_suppl), 4591-4591.
Catto JWF, Hussain SA, Tran B, Pignot G, Master V, Rouprêt M, Tubaro A, Shimizu N, Vasdev N, Nishiyama H , Daneshmand S et al (2024) . Urologic Oncology: Seminars and Original Investigations, 42, S53-S53.
Daneshmand S, Zaucha R, Vasdev N, Gartrell BA, Lotan Y, Hussain SA, Lee EK, Procopio G, Galanternik F, Pignot G , Sundi D et al (2024) . Urologic Oncology: Seminars and Original Investigations, 42, S58-S58.
Necchi A, Hussain SA, Loriot Y & de Velasco G (2024) . European Urology, 85, S427-S427.
Smith TAD, West CML, Joseph N, Lane B, Irlam-Jones J, More E, Mistry H, Reeves KJ, Song YP, Reardon M , Hoskin PJ et al (2024) . eBioMedicine, 101, 105032-105032.
Rehan A, Qureshi M, Goktas Aydin S, O'Connor K, Serra M, Charnley N, Muazzam I, Bansal V, Vasudev N, Coe F , Kagzi MM et al (2024) . Journal of Clinical Oncology, 42(4_suppl), 584-584.
Hussain SA, Oughton JB, Smith Whelan R, Green A, Hubbard R, Kennish S, Senior E, Kendall J, McCready D, Collinson FJ , Griffin J et al (2024) . Journal of Clinical Oncology, 42(4_suppl), tps710-tps710.
Qureshi M, Rehan A, Mok WK, Salawu A, Goktas Aydin S, Tay J, Hubbard R, Catto JWF & Hussain SA (2024) . Journal of Clinical Oncology, 42(4_suppl), 586-586.
Griffin J, Down J, Quayle LA, Heath PR, Gibb EA, Davicioni E, Liu Y, Zhao X, Swain J, Wang D , Hussain S et al (2024) . The Journal of Pathology: Clinical Research, 10(2).
Catto JWF, Tran B, Rouprêt M, Gschwend JE, Loriot Y, Nishiyama H, Redorta JP, Daneshmand S, Hussain SA, Cutuli HJ , Procopio G et al (2024) . Annals of Oncology, 35(1), 98-106.
Szabados BE, Nogueron Martinez E, Alvarez Marquez FJ, Castellano Gauna DE, Rodriguez-Vida A, Garcias de Espana MC, Hussain SA, Alvarez Fernandez C, Linch M, Bonfill Abella T , Gross Goupil M et al (2023) . Annals of Oncology, 34, S1201-S1202.
Catto JWF, Tran B, Roupret M, Gschwend JE, Loriot Y, Nishiyama H, Palou J, Daneshmand S, Hussain SA, Cutuli HJ , Procopio G et al (2023) . Annals of Oncology, 34, S1341-S1342.
Jackson-Spence F, Marin AP, Puente J, Molina-Cerrillo J, Hussain SA, Ackerman C, Bonsu N, Kelly J, Loriot Y, Powles TB & Pulido EG (2023) . Annals of Oncology, 34, S1224-S1225.
Naqvi SAA, Riaz IB, He H, Imran M, Orme J, Childs DS, Ravi P, Hussain SA, Singh P & Bryce AH (2023) . Journal of Clinical Oncology, 41(16_suppl), 5088-5088.
Meeks JJ, Black PC, Galsky M, Grivas P, Hahn NM, Hussain SA, Milowsky MI, Steinberg GD, Svatek RS & Rosenberg JE (2023) . European Urology.
Iyer G, Siefker-Radtke A, Milowsky M, Shore N, Gao X, Reimers MA, Hahn N, Cosman R, Matsubara N, Necchi A , Robbrecht D et al (2023) . Cancer Research, 83(8_Supplement), CT119-CT119.
Khetrapal P, Catto J, Ambler G, Williams N, Al-Hammouri T, Khan MS, Thurairaja R, Nair R, Nathan S, Sridhar A , Ahmad I et al (2023) . Journal of Urology, 209(Supplement 4).
Ayaz A, Naqvi SAA, Tripathi N, Ijaz H, Mir SA, Singh P, Hussain SA, Sonpavde GP, McGregor BA, Bryce AH , Riaz IB et al (2023) . Journal of Clinical Oncology, 41(6_suppl), 531-531.
Riaz IB, Naqvi SAA, He H, Siddiqi R, Asghar N, Ravi P, Hussain SA, Singh P & Bryce AH (2023) . Journal of Clinical Oncology, 41(6_suppl), 193-193.
Daneshmand S, Zaucha R, Gartrell BA, Lotan Y, Hussain SA, Lee EK, Procopio G, Galanternik F, Naini V, Carcione J , Triantos S et al (2023) . Journal of Clinical Oncology, 41(6_suppl), 504-504.
Khetrapal P, Catto JWF, Ambler G, Williams NR, Al-Hammouri T, Khan MS, Thurairaja R, Nair R, Nathan S, Sridhar A , Ahmed I et al (2023) . European Urology, 83, S219-S220.
Catto JWF, Mandrik O, Quayle LA, Hussain SA, McGrath J, Cresswell J, Birtle AJ, Jones RJ, Mariappan P, Makaroff LE , Knight A et al (2023) . BJU International.
van der Heijden MS, Powles T, Petrylak D, de Wit R, Necchi A, Sternberg CN, Matsubara N, Nishiyama H, Castellano D, Hussain SA , Bamias A et al (2023) Re: Predictive Biomarkers for Survival Benefit With Ramucirumab in Urothelial Cancer in the RANGE Trial Editorial Comment. JOURNAL OF UROLOGY, 209(1), 291-291.
Crabb SJ, Hussain S, Soulis E, Hinsley S, Dempsey L, Trevethan A, Song Y, Barber J, Frew J, Gale J , Faust G et al (2023) . Journal of Clinical Oncology, 41(1), 54-64.
Conroy S, Pang K, Jubber I, Hussain SA, Rosario DJ, Cumberbatch MG, Catto JWF & Noon AP (2022) . BJUI Compass.
Crabb SJ, Dempsey L, Soulis E, Hinsley S, Song YP, Barber J, Frew J, Gale J, Faust G, Brock S , McGovern UB et al (2022) . Annals of Oncology, 33, S1348-S1348.
Riaz IB, Naqvi SAA, He H, Asghar N, Siddiqi R, Khakwani KZR, Liu H, Hussain SA, Singh P, Murad M & Bryce AH (2022) . Annals of Oncology, 33, S1193-S1193.
Smith TAD, West CM, Lane B, Irlam-Jones J, More E, Mistry H, Hoskin PJ, Hussain SA, Hall E, Porta N , Huddart RA et al (2022) . Annals of Oncology, 33, S1330-S1330.
Jones RJ, Hussain SA, Birtle AJ, Song YP, Enting D, Faust G, Hilman S, Jagdev S, McGovern UB, Parikh O , Lewis A et al (2022) . Journal of Clinical Oncology, 40(17_suppl), lba4505-lba4505.
Ferm S, Zheng K, Cheng ZA, Tsistrakis S, Nadella D, Gemei A, Fisher C, Hussain S & Kim SH (2022) . Gastrointestinal Endoscopy, 95(6), AB287-AB287.
Ikram W, Naqvi SAA, Raina A, Fatima E, Siddiqi R, Islam M, Asghar N, Khakwani KZR, Khan AM, Hussain SA , Bryce AH et al (2022) . Journal of Clinical Oncology, 40(16_suppl), 4594-4594.
Conroy S, Hubbard R, Noon AP, Hussain SA, Griffin J, Kennish S & Catto JWF (2022) . BJU International, 129(6), 691-694.
Catto JWF, Khetrapal P, Ricciardi F, Ambler G, Williams NR, Al-Hammouri T, Khan MS, Thurairaja R, Nair R, Feber A , Dixon S et al (2022) . JAMA.
Riaz IB, Islam M, Khan AM, Naqvi SAA, Siddiqi R, Khakwani KZR, Asghar N, Ikram W, Hussain SA, Singh P , Warner JL et al (2022) . Am J Med.
Shimizu N, Hussain SA, Obara W, Yamasaki T, Takashima S, Hasegawa T, Iguchi M, Igarashi K, Ogawa O & Fujioka T (2022) . Bladder Cancer, 1-14.
Hussain SA, Lester JF, Jackson R, Gornall M, Qureshi M, Elliott A, Crabb SJ, Huddart RA, Vasudev N, Birtle AJ , Worlding J et al (2022) . The Lancet Oncology, 23(5), 650-658.
van der Heijden MS, Powles T, Petrylak D, de Wit R, Necchi A, Sternberg CN, Matsubara N, Nishiyama H, Castellano D, Hussain SA , Bamias A et al (2022) . Nature Communications, 13.
Vogelzang NJ, Beer TM, Gerritsen W, Oudard S, Wiechno P, Kukielka-Budny B, Samal V, Hajek J, Feyerabend S, Khoo V , Stenzl A et al (2022) . JAMA Oncology, 8(4), 546-546.
Riaz IB, Islam M, Ikram W, Naqvi SAA, Maqsood H, Saleem Y, Riaz A, Ravi P, Hussain SA, Warner JL , Odedina F et al (2022) . Journal of Clinical Oncology, 40(6_suppl), 26-26.
Ikram W, Naqvi SAA, Fatima E, Siddiqi R, Islam M, Asghar N, Khakwani KZR, Khan AM, Xu W, Hussain SA , Sonpavde GP et al (2022) . Journal of Clinical Oncology, 40(6_suppl), 518-518.
Crabb SJ, Hussain SA, Soulis E, Hinsley S, Dempsey L, Trevethan A, Song YP, Barber J, Frew JA, Gale J , Faust G et al (2022) . Journal of Clinical Oncology, 40(6_suppl), 436-436.
Riaz IB, Naqvi SAA, Ikram W, Siddiqi R, Asghar N, Khakwani KZR, Khalid A, Hussain SA, Singh P & Bryce AH (2022) . Journal of Clinical Oncology, 40(6_suppl), 132-132.
Hussain SA, Qureshi M, Tahir B, Rehan A & Catto JWF (2022) . Journal of Clinical Oncology, 40(6_suppl), 461-461.
Catto JWF, Kelly JD, Khetrapal P, Ambler G, Ricciardi F, Khan S, Feber A, Dixon S, Williams N, Ahmed I , Charlesworth P et al (2022) . European Urology, 81, S1125-S1125.
Hall E, Hussain SA, Porta N, Lewis R, Crundwell M, Jenkins P, Rawlings C, Tremlett J, Sreenivasan T, Wallace J , Syndikus I et al (2022) . European Urology.
Ansari J, Eltigani Mohmmed Y, Ghazal-Aswad S, Ansari H, Akhter SMJ, Hassoun Hadid O, Rizwan S, Almazrouei R, Dawoud E, Azribi F , Elhasin H et al (2021) . Gynecologic Oncology Reports, 38.
Baek S, Cohen J, Ferm S, Fisher C, Kim M, Wongvravit J, Hussain S & Kim SH (2021) . The American Journal of Gastroenterology, 116(1), s1079-s1080.
Cohen J, Fisher C, Baek S, Kim M, Wongvravit J, Cheng A, Kim SH & Hussain S (2021) . The American Journal of Gastroenterology, 116(1), s1002-s1002.
Zheng K, Baek S, Hussain S & Kim SH (2021) . The American Journal of Gastroenterology, 116(1), s1008-s1008.
Ansari J, Farrag A, Ali A, Abdelgelil M, Murshid E, Alhamad A, Ali M, Ansari H, Hussain S & Glaholm J (2021) . Molecular and Clinical Oncology, 15(4).
Mariappan P, Ahmad I, Amer T, Andersen LD, Baker S, Bhatt J, Brown M, Bryan R, Catto JWF, Chahal R , Chapman A et al (2021) . European Urology Focus.
Powles T, Csőszi T, Özgüroğlu M, Matsubara N, Géczi L, Cheng SY-S, Fradet Y, Oudard S, Vulsteke C, Morales Barrera R , Fléchon A et al (2021) . The Lancet Oncology, 22(7), 931-945.
Hussain SA, Porta N, Hall E, Qureshi M, Lewis R, Huddart R & James ND (2021) . Eur Urol.
Latif MF, Azam F, Tirmazy SH, Bashir S, Ibnshamsah F, Al Selwi WM, Bukhari N, Alwbari A, Alshangiti A, Gabsi A , Al-Shamsi HO et al (2021) . Journal of Clinical Oncology, 39(15_suppl), e24105-e24105.
Riaz IB, Islam M, Khan AM, Naqvi SAA, Siddiqi R, Hussain SA, Singh P, Warner JL, Sonpavde GP, Duma N & Bryce AH (2021) . Journal of Clinical Oncology, 39(15_suppl), 6549-6549.
Pond GR, Agarwal A, Ornstein M, Garcia J, Gupta R, Grivas P, Drakaki A, Lee J-L, Kanesvaran R, Lorenzo GD , Verolino P et al (2021) . Clinical Genitourinary Cancer.
Riaz IB, He H, Ryu AJ, Siddiqi R, Naqvi SAA, Yao Y, Husnain M, Narasimhulu DM, Mathew J, Sipra QUAR , Vandvik PO et al (2021) . European Urology.
Hussain SA, Shimizu N, Obara W, Yamasaki T, Takashima S, Hasegawa T, Iguchi M, Igarashi K, Ogawa O & Fujioka T (2021) . Journal of Clinical Oncology, 39(6_suppl), 440-440.
Catto JWF, Downing A, Mason S, Wright P, Absolom K, Bottomley S, Hounsome L, Hussain S, Varughese M, Raw C , Kelly P et al (2021) . European Urology.
Williams ST, El Badri S & Hussain SA (2021) . British Journal of Cancer.
Hussain SA, Porta N, Hall E, Salawu A, Lewis R, Sreenivasan T, Wallace J, Crundwell M, Jenkins P, Tremlett J , Huddart R et al (2021) . European Urology, 79(2), 307-315.
Powles T, van der Heijden MS, Castellano D, Galsky MD, Loriot Y, Petrylak DP, Ogawa O, Park SH, Lee J-L, De Giorgi U , Bögemann M et al (2020) . The Lancet Oncology, 21(12), 1574-1588.
Riaz IB & Hussain SA (2020) . European Urology.
Reed O, Jubber I, Griffin J, Noon A, Goodwin L, Hussain S, Cumberbatch M & Catto J (2020) Occupational Bladder cancer: A cross section survey of previous employments, tasks and exposures matched to cancer phenotypes. PLoS ONE.
Martinez Chanza N, Werner L, Plimack E, Yu EY, Alva AS, Crabb SJ, Powles T, Rosenberg JE, Baniel J, Vaishampayan UN , Berthold DR et al (2020) . European Urology Oncology, 3(5), 671-679.
Cohen J, Pakala T, Baek S, Kim M, Shah D, Hussain S, Kim SH & Gutkin E (2020) . The American Journal of Gastroenterology, 115(1), s1628-s1628.
Cohen J, Tsistrakis S, Hussain S, Kim SH & Nussbaum M (2020) . The American Journal of Gastroenterology, 115(1), s1475-s1475.
Cohen J, Schwarzbaum D, Tsistrakis S, Kim SH & Hussain S (2020) . The American Journal of Gastroenterology, 115(1), s1240-s1240.
Schwarzbaum D, Cohen J, Kim M, Baek S, Ferm S, Shah D, Hussain S & Kim SH (2020) . The American Journal of Gastroenterology, 115(1), s300-s300.
Ürün Y, Hussain SA, Bakouny Z, Castellano D, Kılıçkap S, Morgan G, Mckay RR, Pels K, Schmidt A, Doroshow DB , Schütz F et al (2020) . Jco Global Oncology, 6, 1248-1257.
Al-Jameel W, Gou X, Forootan SS, Fayi MSA, Rudland PS, Forootan FS, Zhang J, Cornford PA, Hussain SA & Ke Y (2020) . Oncotarget, 11(31), 3025-3025.
Pang KH, Thomas F, Novara G, Din OS, Morgan SL, Hussain SA, Jubber I, Noon AP, Catto JWF & Rosario DJ (2020) . European Urology Focus.
Fulton B, Jones R, Powles T, Crabb S, Paul J, Birtle A, Chowdhury S, Hussain S, Morris A, Soulis E & Morrison P (2020) . Trials, 21.
Huddart R, Hall E, Lewis R, Porta N, Hussain SA & James ND (2020) . European Urology, 77(6), e156-e157.
Hussain SA, Lester JF, Jackson R, Gornall M, Elliott A, Crabb SJ, Huddart RA, Vasudev N, Birtle AJ, Worlding J , James ND et al (2020) . Journal of Clinical Oncology, 38(6_suppl), 438-438.
James ND, Pirrie S, Liu W, Ford D, Zarkar A, Southgate E, Desai A & Hussain SA (2020) . Journal of Clinical Oncology, 38(6_suppl), 491-491.
Andrews E, Curran C, Grivas P, Diamantopoulos LN, Drakaki A, Jain RK, Tandon A, Agarwal N, Tripathi A, Santos VS , Hussain SA et al (2020) . Journal of Clinical Oncology, 38(6_suppl), 580-580.
Huddart R, Hall E, Lewis R, Porta N, Crundwell M, Jenkins P, Rawlings C, Tremlett J, Campani L, Hendron C , Hussain S et al (2020) . European Urology, 77(2), 260-268.
Elmetwali T, Salman A, Wei W, Hussain SA, Young LS & Palmer DH (2020) . Scientific Reports, 10(1).
Petrylak DP, de Wit R, Chi KN, Drakaki A, Sternberg CN, Nishiyama H, Castellano D, Hussain SA, Fléchon A, Bamias A , Yu EY et al (2020) . The Lancet Oncology, 21(1), 105-120.
van der Heijden M, Powles T, Petrylak D, de Wit R, Chi K, Necchi A, Sternberg CN, Matsubara N, Nishiyama H, Castellano D , Hussain S et al (2019) . Annals of Oncology, 30, v373-v374.
Pakala T, Cohen J, Bunim A & Hussain S (2019) . The American Journal of Gastroenterology, 114(1), s1304-s1304.
Brodsky T, Rubin M, Karaptis J, Hussain S & Kim S (2019) . American Journal of Gastroenterology, 114(1), S315-S315.
Hussain S, Parker S, Edwards K, Finch J, Jeanjean A, Leigh R & Gonem S (2019) . Annals of Allergy, Asthma & Immunology, 123(4), 375-380.e3.
Elander NO & Hussain SA (2019) . European Urology, 76(5), 604-606.
Grimm M-O, Bex A, De Santis M, Ljungberg B, Catto JWF, Rouprêt M, Hussain SA, Bellmunt J, Powles T, Wirth M & Van Poppel H (2019) . European Urology, 76(3), 368-380.
Bamias A, Hegele A, Medioni J, Castellano D, Doni L, Passalacqua R, Zagouri F, Tzannia K, Hussain S & Ullen A (2019) . Critical Reviews in Oncology and Hematology.
Hussain SA, Maroto P, Climent MÁ, Bianchini D, Jones RH, Lin C-C, Wang S-S, Dean E, Crossley K, Schlieker L , Bogenrieder T et al (2019) . Journal of Clinical Oncology, 37(15_suppl), 5030-5030.
Agarwal A, Pond GR, Gupta R, Ornstein MC, Barata PC, Garcia JA, Drakaki A, Lee J-L, Kanesvaran R, Bilen MA , Lorenzo FR et al (2019) . Journal of Clinical Oncology, 37(15_suppl), e16024-e16024.
Park SH, Loriot Y, Zhong B, Hussain SA, Mahadevia PJ, De Porre P & Siefker-Radtke AO (2019) . Journal of Clinical Oncology, 37(15_suppl), 4543-4543.
Pakala T, Tong M, Ferm S, Hussain S, Kim SH & Rubin M (2019) . Gastroenterology, 156(6), s-814-s-815.
Perez-Gracia JL, Loriot Y, Rosenberg JE, Powles T, Necchi A, Hussain SA, Morales-Barrera R, Retz MM, Niegisch G, Durán I , Théodore C et al (2019) . European Urology, 75(3), e82-e83.
Agarwal A, Pond GR, Drakaki A, Lee J-L, Bilen MA, Di Lorenzo G, Grivas P, Ornstein MC, Barata PC, Gupta S , Hussain SA et al (2019) . Journal of Clinical Oncology, 37(7_suppl), 432-432.
Slovin S, Hussain S, Saad F, Garcia J, Picus J, Ferraldeschi R, Crespo M, Flohr P, Riisnaes R, Lin C , Keer H et al (2019) . Clinical Cancer Research, 25(15), 4624-4633.
Petrylak DP, Sternberg CN, Drakaki A, de Wit R, Nishiyama H, Necchi A, Castellano D, Bamias A, Chi KN, van der Heijden MS , Matsubara N et al (2018) . Annals of Oncology, 29(suppl_8), viii304-viii305.
Brodsky T, Ferm S, Hassam A, Siu M, Hussain S, Kim S-H, Gutkin E, Bunim A & Rubin M (2018) . The American Journal of Gastroenterology, 113(Supplement), s1553.
Ferm S, Fisher C, Tong M, Rubin M, Hussain S & Kim S-H (2018) . The American Journal of Gastroenterology, 113(Supplement), s96.
Hussain SA, Birtle A, Crabb S, Huddart R, Small D, Summerhayes M, Joners R & Protheroe A (2018) . European Urology Oncology, 1(6), 486-500.
Ferm S, Tong M, Fisher C, Rubin M, Hussain S & Kim SH (2018) . Gastrointestinal Endoscopy, 87(6), ab381.
Ansari J, Farrag AF, Ali A, Ali M, Shaukat AA, Hussein K, Bashir F, Abdel Gelil M, Glaholm J, Hussain SA , Al Hamad A et al (2018) . Journal of Clinical Oncology, 36(15_suppl), e15078-e15078.
Pakala T, Kim SH, Hussain S, Chang R & Rubin M (2018) . Gastroenterology, 154(6), s-300-s-301.
Perez-Gracia JL, Loriot Y, Rosenberg JE, Powles T, Necchi A, Hussain SA, Morales-Barrera R, Retz MM, Niegisch G, Durán I , Théodore C et al (2018) . European Urology, 73(3), 462-468.
Passalacqua R, Medioni J, Castellano DE, Ullén A, Bamias A, Hussain S & Hegele A (2018) . Journal of Clinical Oncology, 36(6_suppl), 463-463.
Powles T, Durán I, van der Heijden MS, Loriot Y, Vogelzang NJ, De Giorgi U, Oudard S, Retz MM, Castellano D, Bamias A , Fléchon A et al (2018) . The Lancet, 391(10122), 748-757.
Ramos JD, Wingate JT, Gulati R, Plimack ER, Harshman LC, Powles T, Crabb SJ, Niegisch G, Bellmunt J, Ladoire S , De Giorgi U et al (2018) . Clinical Genitourinary Cancer, 16(1), e161-e167.
Necchi A, Pond GR, Smaldone MC, Pal SK, Chan K, Wong Y-N, Viterbo R, Sonpavde G, Harshman LC, Crabb S , Alva A et al (2018) . European Urology Focus, 4(6), 937-945.
Petrylak DP, de Wit R, Chi KN, Drakaki A, Sternberg CN, Nishiyama H, Castellano D, Hussain S, Fléchon A, Bamias A , Yu EY et al (2017) . The Lancet, 390(10109), 2266-2277.
Petrylak DP, Chi KN, Drakaki A, Sternberg CN, de Wit R, Nishiyama H, Yu EY, Castellano D, Hussain S, Percent IJ , Fléchon A et al (2017) . Annals of Oncology, 28, v621.
Jones RJ, Hussain SA, Protheroe AS, Birtle A, Chakraborti P, Huddart RA, Jagdev S, Bahl A, Stockdale A, Sundar S , Crabb SJ et al (2017) . Journal of Clinical Oncology, 35(16), 1770-1777.
Lurie LB, Brodsky T, Hussain S, Kim SH & Rubin M (2017) . Gastrointestinal Endoscopy, 85(5), ab645.
Carr DF, Ayehunie S, Davies A, Duckworth CA, French S, Hall N, Hussain S, Mellor HR, Norris A, Park BK , Penrose A et al (2017) . Pharmacology & Therapeutics, 172, 181-194.
Al-Jameel W, Gou X, Forootan SS, Al Fayi MS, Rudland PS, Forootan FS, Zhang J, Cornford PA, Hussain SA & Ke Y (2017) . OncoTargets and Therapy, 8(19), 31041-31056.
Hussain SA, Palmer DH, Syn WK, Sacco JJ, Greensmith RM, Elmetwali T, Aachi V, Lloyd BH, Jithesh PV, Arrand J , Barton D et al (2017) . International journal of oncology, 50(4), 1147-1159.
Hall E, Hussain SA, Porta N, Crundwell M, Jenkins P, Rawlings CL, Tremlett J, Friend C, Stubbs C, Lewis R , James ND et al (2017) . Journal of Clinical Oncology, 35(6_suppl), 280-280.
Hussain SA, Gomberg S, Probert C, Hickerton B, Jackson R & Weston R (2017) . Journal of Clinical Oncology, 35(6_suppl), 339-339.
Perez-Gracia JL, Loriot Y, Rosenberg JE, Powles T, Necchi A, Hussain SA, Morales R, Retz M, Niegisch G, Duran I , Theodore C et al (2017) . Journal of Clinical Oncology, 35(6_suppl), 323-323.
Mateo J, Mossop H, Goodall J, Lorente D, Porta N, Carreira S, Miranda S, Zafeiriou Z, Ralph C, Jain S , Jones RJ et al (2017) . Journal of Clinical Oncology, 35(6_suppl), 141-141.
Huddart R, Hall E, Miranda M, Crundwell M, Jenkins P, Rawlings C, Tremlett J, Hendron C, Lewis R, Porta N , Hussain S et al (2017) . European Journal of Cancer, 72, s186-s187.
Choudhury A, West CM, Porta N, Hall E, Denley H, Hendron C, Lewis R, Hussain SA, Huddart R & James N (2017) . British Journal of Cancer, 116(5), 649-657.
Hussain SA, Ansari J, Huddart R, Power DG, Lyons J, Wylie J, Vilarino-Varlela M, Elander NO, McMenemin R, Pickering LM , Faust G et al (2017) . International journal of oncology, 50(3), 768-772.
Powles T, Huddart RA, Elliott T, Sarker S-J, Ackerman C, Jones R, Hussain S, Crabb S, Jagdev S, Chester J , Hilman S et al (2017) . Journal of Clinical Oncology, 35(1), 48-55.
Al Fayi MS, Gou X, Forootan SS, Al-Jameel W, Bao Z, Rudland PR, Cornford PA, Hussain SA & Ke Y (2016) . Oncotarget, 7(50), 82783-82797.
Bellmunt J, Balar A, Galsky MD, Loriot Y, Theodore C, Grande Pulido E, Castellano D, Retz M, Niegisch G, Bracarda S , Necchi A et al (2016) . Annals of Oncology, 27, vi270-vi270.
Loriot Y, Rosenberg JE, Powles TB, Necchi A, Hussain S, Morales R, Retz M, Niegisch G, Duran I, Theodore C , Perez-Gracia JL et al (2016) . Annals of Oncology, 27, vi270.
Smith M, De Bono J, Sternberg C, Le Moulec S, Oudard S, De Giorgi U, Krainer M, Bergman A, Hoelzer W, De Wit R , Bögemann M et al (2016) . Journal of Clinical Oncology, 34(25), 3005-3013.
Locke JA, Pond GR, Sonpavde G, Necchi A, Giannatempo P, Paluri RK, Niegisch G, Albers P, Buonerba C, Di Lorenzo G , Vaishampayan UN et al (2016) . Clinical Genitourinary Cancer, 14(4), 331-340.
Andronis L, Goranitis I, Pirrie S, Pope A, Barton D, Collins S, Daunton A, McLaren D, O'Sullivan JM, Parker C , Porfiri E et al (2016) . BJU International.
Jones RH, Anthoney DA, Jones RJ, Crabb SJ, Hussain SA, Birtle AJ, Spiliopoulou P, Robinson T, Knowles M, McLellan L , Jones H et al (2016) . Journal of Clinical Oncology, 34(15_suppl), 4521-4521.
Latif MF, Tirmazy SH, Hussain SA, Jackson R, Barnett C & Azam F (2016) . Journal of Clinical Oncology, 34(15_suppl), e16520-e16520.
Elander NO & Hussain SA (2016) PARP Inhibition in Prostate Cancer: A Promising Approach. Oncology, 30(5), 393-394.
James ND, Pirrie SJ, Pope AM, Barton D, Andronis L, Goranitis I, Collins S, Daunton A, McLaren D, O’Sullivan J , Parker C et al (2016) . JAMA Oncology, 2(4), 493-493.
Dreicer R, van der Heijden MS, Grivas P, Hoffman-Censits J, Loriot Y, Retz M, Vogelzang NJ, Perez-Gracia JL, Kalebasty AR, Bracarda S , Yu EY et al (2016) . Investigative Urology, 195(4), e654.
El-Taji OMS, Alam S & Hussain SA (2016) . Current Treatment Options in Oncology, 17(3).
Powles T, Wheater M, Din O, Geldart T, Boleti E, Stockdale A, Sundar S, Robinson A, Ahmed I, Wimalasingham A , Burke W et al (2016) . European Urology, 69(3), 450-456.
Forootan FS, Forootan SS, Gou X, Yang J, Liu B, Chen D, Fayi MSA, Al-Jameel W, Rudland PS, Hussain SA & Ke Y (2016) . Oncotarget, 7(8), 9322-9339.
Powles T, Hussain SA, Protheroe A, Birtle A, Chakraborti PR, Huddart R, Jagdev S, Bahl A, Stockdale A, Sundar S , Crabb SJ et al (2016) . Journal of Clinical Oncology, 34(2_suppl), 430-430.
Hussain SA, Khattak AQ, Cornford P, Weston R, Somov P & Jackson R (2016) . Journal of Clinical Oncology, 34(2_suppl), 396-396.
Hoffman-Censits JH, Grivas P, Van Der Heijden MS, Dreicer R, Loriot Y, Retz M, Vogelzang NJ, Perez-Gracia JL, Rezazadeh A, Bracarda S , Yu EY et al (2016) . Journal of Clinical Oncology, 34(2_suppl), 355-355.
Ramos J, Wong Y-N, Crabb SJ, Niegisch G, Bellmunt J, Ladoire S, Hussain SA, Baniel J, Golshayan AR, Powles T , Rosenberg JE et al (2016) . Journal of Clinical Oncology, 34(2_suppl), 422-422.
Nedjadi T, Al-Ammari A, Khayyat D, Salem N, Al-Sayyad A, Hussain SA, Azhar E, Damanhouri G & Al-Maghrabi J (2016) The cell cycle regulator p27^Kip1 is associated with urothelial bladder cancer invasion. International Journal of Clinical and Experimental Pathology, 9(10), 10515-10521.
Mateo J, Carreira S, Sandhu S, Miranda S, Mossop H, Perez-Lopez R, Nava Rodrigues D, Robinson D, Omlin A, Tunariu N , Boysen G et al (2015) . New England Journal of Medicine, 373(18), 1697-1708.
Harshman L, Werner L, Wong YN, Yu E, Alva A, Crabb S, Powles T, Rosenberg J, Baniel J, Vaishampayan U , Berthold D et al (2015) . European Journal of Cancer, 51, S518-S518.
Hussain S, Jackson R, Chauhan S, Ansari J, Huddart R, Harrold E, Power D, Lyons J, Wylie J, Vilarino-Varela M , Wilkinson D et al (2015) . European Journal of Cancer, 51, s523.
Ananya C, West C, Porta N, Denley H, Hendron C, Hussain S, Hall E, Huddart R & James N (2015) . European Journal of Cancer, 51, s527-s528.
Galsky MD, Pal SK, Chowdhury S, Harshman LC, Crabb SJ, Wong Y-N, Yu EY, Powles T, Moshier EL, Ladoire S , Hussain SA et al (2015) . Cancer, 121(15), 2586-2593.
Sundaram V, Hshieh T, Curry M, Kaung A & Hussain S (2015) . Saudi Journal of Gastroenterology, 21(4), 254-254.
EL-TAJI OMS, KHATTAK AQ & HUSSAIN SA (2015) . Oncology Letters, 10(1), 3-10.
Harshman LC, Werner L, Wong Y-N, Yu EY, Alva AS, Crabb SJ, Powles T, Rosenberg JE, Baniel J, Vaishampayan UN , Berthold DR et al (2015) . Journal of Clinical Oncology, 33(15_suppl), 4524-4524.
Powles T, Huddart RA, Elliott T, Jones R, Hussain SA, Crabb SJ, Ackerman C, Jagdev S, Chester JD, Hilman S , Beresford M et al (2015) . Journal of Clinical Oncology, 33(15_suppl), 4505-4505.
Necchi A, Pond GR, Giannatempo P, Di Lorenzo G, Eigl BJ, Locke J, Pal SK, Agarwal N, Poole A, Vaishampayan UN , Niegisch G et al (2015) . Clinical Genitourinary Cancer, 13(2), 178-184.
Hussain SA, Ansari J, Huddart RA, Wylie J, Vilarino-Varela M, Faust G, Tan M, Lyons J, Hassall A, Escriu C , Chauhan S et al (2015) . Journal of Clinical Oncology, 33(7_suppl), 352-352.
Hussain SA, Jackson R, Shields A, Dickinson L, Cornford P, Jones RJ, Lester JF, Chester J, Birtle AJ, Powles T , Crabb SJ et al (2015) Phase II randomised placebo controlled neoadjuvant chemotherapy study of nintedanib with gemcitabine and cisplatin in locally advanced muscle invasive bladder cancer. Journal of Clinical Oncology, 33 (supplement; abstract TPS4574).
Sharma S, Witteveen PO, Lolkema MP, Hess D, Gelderblom H, Hussain SA, Porro MG, Waldron E, Valera S-Z & Mu S (2015) . Cancer Chemotherapy and Pharmacology, 75(1), 87-95.
Porro M, Sharma S, Witteveen PO, Lolkema MP, Hess D, Gelderblom H, Hussain SA, Waldron E, Valera S & Mu S (2014) . European Journal of Cancer, 50, 185.
Sonpavde G, Necchi A, Giannatempo P, Di Lorenzo G, Eigl BJ, Locke J, Pal S, Agarwal N, Poole A, Vaishampayan UN , Niegisch G et al (2014) . Annals of Oncology, 25, iv302.
Ferraldeschi R, Slovin S, Hussain S, Saad F, Garcia J, Kabbinavar FF, Uppal N, Vogelzang NJ, Poiesz BJ, Gelmann E , Picus J et al (2014) . Annals of Oncology, 25, iv267.
Hayden A, Douglas J, Sommerlad M, Andrews L, Gould K, Hussain S, Thomas GJ, Packham G & Crabb SJ (2014) . Urologic Oncology: Seminars and Original Investigations, 32(6), 806-814.
Jones RJ, Chester JD, Dixon-Hughes J, Alexander L, Bahl A, Hussain SA, Birtle A, Jagdev S, Morris A, Stobo J , Bray CA et al (2014) . Journal of Clinical Oncology, 32(15_suppl), tps4589-tps4589.
Galsky MD, Harshman LC, Crabb SJ, Wong Y-N, Yu EY, Chowdhury S, Powles T, Pal SK, Moshier EL, Ladoire S , Hussain SA et al (2014) . Journal of Clinical Oncology, 32(15_suppl), 4512-4512.
Wang WJ, Gray S, Sison C, Arramraju S, John BK, Hussain SA, Kim SH, Mehta P & Rubin M (2014) . Therapeutic Advances in Gastroenterology, 7(1), 14-19.
Johnson PJ, Pirrie SJ, Cox TF, Berhane S, Teng M, Palmer D, Morse J, Hull D, Patman G, Kagebayashi C , Hussain S et al (2014) . Cancer Epidemiology Biomarkers & Prevention, 23(1), 144-153.
Huddart RA, Hall E, Hussain SA, Jenkins P, Rawlings C, Tremlett J, Crundwell M, Adab FA, Sheehan D, Syndikus I , Hendron C et al (2013) . International Journal of Radiation Oncology*Biology*Physics, 87(2), 261-269.
Bose K, Gutkin E, Kim S, Hussain S, Bunim A & Rubin M (2013) . The American Journal of Gastroenterology, 108, s628.
Maughan BL, Agarwal N, Hussain SA, Boucher KM, Von Der Maase H, Kaufman DS, Lorusso V, Moore MJ, Galsky MD & Sonpavde G (2013) . Clinical Genitourinary Cancer, 11(3), 316-320.
Palmer DH, Hussain SA, Smith AJ, Hargreaves S, Ma YT, Hull D, Johnson PJ & Ross PJ (2013) . British Journal of Cancer, 109(4), 888-890.
James ND, Pirrie S, Barton D, Brown JE, Billingham L, Collins SI, Daunton A, Birtle AJ, Chakraborti PR, Ford D , Hussain SA et al (2013) . Journal of Clinical Oncology, 31(18_suppl), LBA5000-LBA5000.
James ND, Pirrie S, Barton D, Brown JE, Billingham L, Collins SI, Daunton A, Birtle AJ, Chakraborti PR, Ford D , Hussain SA et al (2013) . Journal of Clinical Oncology, 31(15_suppl), lba5000-lba5000.
Hussain SA, Palmer DH, Syn WK, Sacco JJ, Lloyd B, Jithesh P, Arrand JR, Barton D, Ansari J, Sibson DR & James ND (2013) . Journal of Clinical Oncology, 31(15_suppl), 4518-4518.
Gutkin E, Shalomov A, Hussain SA, Kim SH, Cortes R, Gray S, Judeh H, Pollack S & Rubin M (2013) . Therapeutic Advances in Gastroenterology, 6(3), 193-198.
James ND & Hussain SA (2013) . American Society of Clinical Oncology Educational Book, 33, 200-206.
Gutkin E, Hussain SA & Kim SH (2012) . Digestive Endoscopy, 24(6), 482-482.
NICI AJ, HUSSAIN SA, KIM SH & MEHTA P (2012) . Digestive Endoscopy, 24(3), 185-187.
James ND, Hussain SA, Hall E, Jenkins P, Tremlett J, Rawlings C, Crundwell M, Sizer B, Sreenivasan T, Hendron C , Lewis R et al (2012) . New England Journal of Medicine, 366(16), 1477-1488.
Nici AJ, Gutkin E, Wang WJ, Kim SH, Hussain SA & Rubin M (2012) . Gastrointestinal Endoscopy, 75(4), ab481-ab482.
Gutkin E, Hussain SA, Mehta P, Kim SH, Pollack S & Rubin M (2012) . Gastroenterology Res, 5(2), 52-56.
Gutkin E, Hussain SA & Kim SH (2012) . Journal of Addiction Medicine, 6(1), 89-91.
Ansari J, White L, Glen H, McGlynn B, Nairn R, Balsitis M, Hollins G, Smith K, Nair B, Gurun M , Little B et al (2012) . Journal of Clinical Oncology, 30(5_suppl), 167-167.
Agarwal N, Boucher KM, Maughan B, Hussain SA, Kaufman DS, Lorusso V, Moore MJ, Galsky MD & Sonpavde G (2012) . Journal of Clinical Oncology, 30(5_suppl), 308-308.
Ma YT, Hussain SA, Johnson PJ & Palmer DH (2012) . Journal of Clinical Oncology, 30(4_suppl), 372-372.
Gutkin E, Hussain SA & Kim SH (2012) . Gut and Liver, 6(1), 136-138.
Bryan RT, Wei W, Shimwell NJ, Collins SI, Hussain SA, Billingham LJ, Murray PG, Deshmukh N, James ND, Wallace DMA , Johnson PJ et al (2011) . PROTEOMICS - Clinical Applications, 5(9-10), 493-503.
Gutkin E, Nici A, Shalomov A, Hussain S, Mehta P, Rubin M & Kim S (2011) . The American Journal of Gastroenterology, 106, s559.
Nici A, Hussain S & Kim S (2011) . The American Journal of Gastroenterology, 106, s377.
Gutkin E, Hussain S, Shalomov A, Kim SH, Mehta P, Du L & Rubin M (2011) Diagnosis of multifocal small bowel carcinoid with double balloon Enteroscopy. Practical Gastroenterology, 35(9), 60-63.
Shalomov A, Hussain SA, Kim SH, Palumbo FM & Rubin M (2011) . Gastrointestinal Endoscopy, 73(4), ab465.
Mandair DS, Bridgestock H, Shah T, Mangat K, Olliff S, Mahon B, Hussain S, Johnson P & Palmer D (2011) . Gut, 60(Suppl 1), a115.
Rubin M, Hussain SA, Shalomov A, Cortes RA, Smith MS & Kim SH (2011) . Digestive Diseases and Sciences, 56(3), 786-791.
Ansari J, A Hussain S, Alhasso A, Mahmood R, Ansari A & Glaholm J (2011) . Anti-Cancer Agents in Medicinal Chemistry, 11(3), 296-306.
Hussain S, Ma YT & Cullen MH (2011) Tumour biology of germ cell tumours. Hematology/Oncology Clinics of North America, 25, 457-471.
Ma YT, Cullen MH & Hussain SA (2011) . Hematology/Oncology Clinics of North America, 25(3), 457-471.
Hassan MSU, Ansari J, Spooner D & Hussain SA (2010) . Oncology Reports, 24(5), 1121-1131.
James N, Hussain S, Hall E, Jenkins P, Tremlett J, Rawlings C, Crundwell M, Waters R & Huddart RA (2010) . International Journal of Radiation Oncology • Biology • Physics, 78(3), s2-s3.
Hussain S, Judeh H, Kim S & Mehta P (2010) . The American Journal of Gastroenterology, 105, s198.
Hussain SA, Palmer DH, Ward DH, Arrand JR, Collins SI, Barton D, Martin A, Porfiri E, Wallace M & James ND (2010) . Journal of Clinical Oncology, 28(15_suppl), e15118-e15118.
James ND, Hussain SA, Hall E, Jenkins P, Tremlett J, Rawlings C, Hendron C, Lewis R, Rogers S & Huddart RA (2010) . Journal of Clinical Oncology, 28(15_suppl), 4517-4517.
Gutkin E, Gray S, Judeh H, Shalomov A, Hussain SA, Cortes RA, Kim SH & Rubin M (2010) . Gastrointestinal Endoscopy, 71(5), ab157-ab158.
Zeegers MP, Bryan RT, Langford C, Billingham L, Murray P, Deshmukh NS, Hussain S, James N, Wallace DMA & Cheng KK (2010) . BJU International, 105(6), 784-788.
Ansari J, Glaholm J, McMenemin R, James ND & Hussain SA (2010) . Anti-Cancer Agents in Medicinal Chemistry, 10(3), 225-235.
(2010) . Hemodialysis International, 14(1), 152-152.
Hussain S, Ansari J & Spooner D (2010) Advances in chemotherapy in breast cancer.. Oncology Report, 24, 1121-1131.
Hussain SA, Esposito SP & Rubin M (2009) . Digestive Diseases and Sciences, 54(10), 2296-2297.
Shalomov A, Hussain S, Cortes R, Kim S, Brodsky N, Somnay K, Smith M & Rubin M (2009) . The American Journal of Gastroenterology, 104, s502.
Shalomov A, Hussain S, Cortes R, Kim S, Somnay K, Brodsky N, Smith M & Rubin M (2009) . The American Journal of Gastroenterology, 104, s401.
Huddart R, James ND, Adab F, Syndikus I, Jenkins P, Rawlings C, Rogers S, Lewis R, Hendron C, Hussain S & Hall E (2009) . European Journal of Cancer Supplements, 7(2), 423-423.
Hussain SA & Cohen EP (2009) . Nephrology Dialysis Transplantation, 24(7), 2290-2290.
Ansari J, Palmer D, Rea D & Hussain S (2009) . Anti-Cancer Agents in Medicinal Chemistry, 9(5), 569-575.
Chue AL, Walji N, Rogers LJ, Hussain SA, Chan KK, Singh K & Fernando IN (2009) . Journal of Clinical Oncology, 27(15_suppl), e16543-e16543.
Walji N, Zachariah A, Yap C, Hussain SA, Poole CJ, El-Modir A, Ganesan R & Fernando IN (2009) . Journal of Clinical Oncology, 27(15_suppl), e16539-e16539.
HUSSAIN S, PIERING W, MOHYUDDIN T, SALEH M, ZHU Y-R, HANAN M & COHEN E (2009) . Hemodialysis International, 13(2), 205-214.
Hussain S, Ansari J, McMenemin R & Glaholm J (2009) Re-challenging with Docetaxel chemotherapy following relapse: Is this an effective treatment strategy. Prostate Cancer Forum, 5, 1-9.
Chue AL, Fernando IN, Hussain SA & Yates DA (2009) . Cases Journal, 2(1), 8526-8526.
Hussain SA, Ma YT, Palmer DH, Hutton P & Cullen MH (2008) . Expert Review of Anticancer Therapy, 8(10), 1659-1673.
James ND, Hussain SA, Tremlett J, Crundwell M, Jenkins P, Rawlings C, Hall E, Rogers S & Huddart R (2008) . International Journal of Radiation Oncology • Biology • Physics, 72(1), s7.
Tanguay JS, Buckley L, Hussain SA & Fernando IN (2008) . Journal of Clinical Oncology, 26(15_suppl), 16539-16539.
Ansari J, Hussain SA, Zarkar A, Bliss J, Tanguay JS & Glaholm J (2008) . Journal of Clinical Oncology, 26(15_suppl), 16066-16066.
John BK, Dang NC, Hussain SA, Yang GCH, Cham MD, Yantiss R, Joseph AS, Giashuddin SM, Lee PC, Fleming R & Somnay K (2008) . Journal of Gastrointestinal Cancer, 39(1-4), 107-113.
Hussain S, Pascoe J, Palmer D, Spooner D & Rea D (2008) . Current Pharmacogenomics and Personalized Medicine, 6(1), 45-55.
Hussain SA, Ting Ma Y & Cullen MH (2008) . Expert Review of Anticancer Therapy, 8(5), 771-784.
Gill JS, Hussain S, Rose C, Hariharan S & Tonelli M (2007) . Journal of the American Society of Nephrology, 18(9), 2592-2599.
Hussain SA, Ward D, Palmer DH, Barton D, Veeranna V, Porfiri E, Martin A, Wallace M & James ND (2007) . Journal of Clinical Oncology, 25(18_suppl), 15551-15551.
Hussain SA, Rea DW & Palmer DH (2007) . British Journal of Cancer, 96(8), 1310-1310.
Hussain SA, Ganesan R, Reynolds G, Gross L, Stevens A, Pastorek J, Murray PG, Perunovic B, Anwar MS, Billingham L , James ND et al (2007) . British Journal of Cancer, 96(1), 104-109.
Hussain SA, Palmer DH, Spooner D & Rea DW (2007) . BioDrugs, 21(4), 215-224.
Hussain S, Rea D, James N & Palmer D (2007) . Current Signal Transduction Therapy, 2(1), 21-30.
Basu PP, Palumbo FM, Maltby M, Hussain S, Somnay K & Mendis RE (2006) . The American Journal of Gastroenterology, 101, s90-s91.
Hussain SA & Hariharan S (2006) . Current Opinion in Organ Transplantation, 11(4), 413-417.
Saad ER, Bresnahan B, Cohen EP, Hussain S, Vasudev B, Orentas R & Hariharan S (2006) . Transplantation, 82(1), 938-939.
Hussain SA, Palmer DH, Swinson DE, Riley P, Brown C, Wills A, El-Modir A, Rea DW, Chetiyawardana AD & Cullen MH (2006) . Journal of Clinical Oncology, 24(18_suppl), 17048-17048.
Vasudev B, Hariharan S, Hussain SA, Zhu Y-R, Bresnahan BA & Cohen EP (2005) . Kidney International, 68(4), 1834-1839.
Hussain SA, Palmer DH, Swinson DE, Bailey C, Billingham L, Riley P, El-Modir A, Rea DW, Chetiyawardana AD & Cullen MH (2005) . Journal of Clinical Oncology, 23(16_suppl), 7272-7272.
Hussain S, Savin V, Piering W, Tomasi J & Blumenthal S (2005) . Hemodialysis International, 9(2), 147-152.
JAMES N & HUSSAIN S (2005) . Seminars in Radiation Oncology, 15(1), 19-27.
Palmer DH, Hussain SA & Johnson PJ (2005) . Expert Opinion on Biological Therapy, 5(4), 507-523.
Hussain SA, Palmer DH, Stevens A, Spooner D, Poole CJ & Rea DW (2005) . Expert Review of Anticancer Therapy, 5(6), 1095-1110.
HUSSAIN S & JAMES N (2005) . Seminars in Radiation Oncology, 15(1), 3-9.
Bryan RT, Hussain SA, James ND, Jankowski JA & Wallace DMA (2005) . BJU International, 95(4), 485-490.
Bryan RT, Hussain SA, James ND, Jankowski JA & Wallace DMA (2005) . BJU International, 95(4), 491-496.
Hussain S & James ND (2005) Management of muscle invasive bladder cancer – can we improve the results of bladder preserving therapy?. Seminars in Radiation Oncology, 15(1), 19-27.
Palmer DH, Hussain SA & Johnson PJ (2004) . Expert Opinion on Investigational Drugs, 13(12), 1555-1568.
Hussain SA, Stocken DD, Riley P, Palmer DH, Peake DR, Geh JI, Spooner D & James ND (2004) . British Journal of Cancer, 91(5), 844-849.
Hussain SA, Stocken DD, Peake DR, Glaholm JG, Zarkar A, Wallace DMA & James ND (2004) . Journal of Clinical Oncology, 22(14_suppl), 4585-4585.
Hussain SA, Stocken DD, Peake DR, Glaholm JG, Zarkar A, Wallace DMA & James ND (2004) . Journal of Clinical Oncology, 22(14_suppl), 4585-4585.
Hussain SA, Stocken DD, Peake DR, Glaholm JG, Zarkar A, Wallace DMA & James ND (2004) . British Journal of Cancer, 90(11), 2106-2111.
Hussain SA, Williams S, Stevens A & Rea DW (2004) . Expert Review of Anticancer Therapy, 4(5), 877-888.
Hussain SA, Palmer DH, Moon S & Rea DW (2004) . Expert Review of Anticancer Therapy, 4(6), 1179-1195.
Hussain S, Ganesan R, Palmer DH, Cooke PW, Wallace DM, Young LS & James ND (2004) CD40 expression in prostatic carcinomas. Oncology Reports: an international journal devoted to fundamental and applied research in oncology, 12(4), 679-682.
Hussain S, Palmer DH, Ganesan R, Hillier L, Gregory J, Pastorek J, Murray P, Young LS & James ND (2004) Role of hypoxic marker CA IX in Transitional cell carcinoma of the bladder.. Oncology Reports: an international journal devoted to fundamental and applied research in oncology, 11(5), 1005-1010.
Hussain S, Williams S, Stevens A & Rea DW (2004) Role of endocrine therapy in early breast cancer. Expert Review of Anticancer Therapy, 5, 877-888.
Hussain S, Palmer DH, Moon S & Rea DW (2004) Role of endocrine therapy in metastatic breast cancer.. Expert Review of Anticancer Therapy, 6, 1179-1195.
Hussain SA & James ND (2003) . The Lancet Oncology, 4(8), 489-497.
McCabe CJ, Khaira JS, Boelaert K, Heaney AP, Tannahill LA, Hussain S, Mitchell R, Olliff J, Sheppard MC, Franklyn JA & Gittoes NJL (2003) . Clinical Endocrinology, 58(2), 141-150.
Hussain SA, Ganesan R, Hiller L, Murray PG, El-Magraby MM, Young L & James ND (2003) . British Journal of Cancer, 88(4), 586-592.
Cohen EP, Hussain S & Moulder JE (2003) . International Journal of Radiation Oncology*Biology*Physics, 55(1), 190-193.
Hussain SA, Ganesan R, Hiller L, Cooke PW, Murray P, Young LS & James ND (2003) BCL2 expression predicts survival in patients receiving synchronous chemoradiotherapy in advanced transitional cell carcinoma of the bladder. Oncology Reports, 10(3), 571-576.
Hussain SA & James ND (2002) . Expert Review of Anticancer Therapy, 2(6), 641-651.
McCabe CJ, Boelaert K, Tannahill LA, Heaney AP, Stratford AL, Khaira JS, Hussain S, Sheppard MC, Franklyn JA & Gittoes NJL (2002) . The Journal of Clinical Endocrinology & Metabolism, 87(9), 4238-4244.
Hussain S, Bresnahan BA, Cohen EP & Hariharan S (2002) . Clinical Transplantation, 16(1), 43-47.
Hussain SA, Moffitt DD, Glaholm JG, Peake D, Wallace DMA & James ND (2001) . Annals of Oncology, 12(7), 929-935.
Mulholland PJ, Ferry DR, Anderson D, Hussain SA, Young AM, Cook JE, Hodgkin E, Seymour LW & Kerr DJ (2001) . Annals of Oncology, 12(2), 245-248.
Chung-Faye G, Palmer D, Anderson D, Clark J, Dowries M, Baddeley J, Hussain S, Murray PI, Searle P, Seymour L , Ferry D et al (2001) Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: A phase I and pharmacokinetic study of its prodrug, CB1954. Clinical Cancer Research, 7(9), 2662-2668.
Hussain SA, Ferry DR, El-Gazzaz G, Mirza DF, James ND, McMaster P & Kerr DJ (2001) . Annals of Oncology, 12(2), 161-172.
Hussain SA & James N (2000) Role of chemotherapy in anal tumours. GI Cancer, 3(3), 181-187.
Ansari (1994) . Oncology Reports, 20(4).
Wheatley DA, Berardi R, Climent Duran MA, Tomiak A, Greystoke AP, Joshua AM, Arkenau H-T, Géczi L, Garcia-Corbacho J, Paz-Ares LG , Hussain SA et al () . Cancer Research Communications.
Jones RJ, Crabb SJ, Linch M, Birtle AJ, McGrane J, Enting D, Stevenson R, Liu K, Kularatne B & Hussain SA () . British Journal of Cancer.
Macaulay VM, Lord S, Hussain S, Maroto JP, Jones RH, Climent MÁ, Cook N, Lin C-C, Wang S-S, Bianchini D , Bailey M et al () . British Journal of Cancer.
Jubber I, Morhardt DR, Griffin J, Cumberbatch M, Glover M, Zheng Y, Rehman I, Loynes C, Hussain SA, Renshaw SA , Leach SD et al () . Disease Models & Mechanisms.
Riaz IB, Naqvi SAA, He H, Asghar N, Siddiqi R, Liu H, Singh P, Childs DS, Ravi P, Hussain SA , Murad MH et al () . JAMA Oncology.
Riaz IB, Islam M, Ikram W, Naqvi SAA, Maqsood H, Saleem Y, Riaz A, Ravi P, Wang Z, Hussain SA , Warner JL et al () . JAMA Oncology.
James ND, Liu W, Pirrie S, Kaur B, Hendron C, Ford D, Zarkar A, Viney R, Southgate E, Desai A & Hussain SA () . BJU International.
Jubber I, Mitchell S, Hussain S, Tsoi H, Catto JWF & Cumberbatch MG () . BJU International.
Gordon NS, Baxter LA, Goel A, Arnold R, Kaur B, Liu W, Pirrie SJ, Hussain S, Viney R, Ford D , Zarkar A et al () . BJU International.
Bin Riaz I, Khan AM, Catto JWF & Hussain SA () . Expert Opinion on Investigational Drugs.
Crabb SJ, Danson S, Catto JWF, Hussain S, Chan D, Dunkley D, Downs N, Marwood E, Day L, Saunders G , Light M et al () . Clinical Cancer Research.
Al-Hujaily E, Khatlani T, Alehaideb Z, Ali R, Almuzaini B, Alrfaei B, Iqbal J, Islam I, Malik S, Marwani B , Massadeh S et al () . Biomedical Reports.
Nici A, Hussain S, Rubin M & Kim S () . Endoscopy, 45(S 02), E307-E308.
Palmer D, Hussain S, Ganesan R, Cooke P, Wallace D, Young L & James N () . Oncology Reports.
Hussain S, Palmer D, Ganesan R, Hiller L, Gregory J, Murray P, Pastorek J, Young L & James N () . Oncology Reports.
() . Journal of Andrology and Gynaecology, 2(3).
Ansari J, Hussain , Glaholm & Ansari A () . Biologics: Targets and Therapy, 39-39.
Simmons J, Hussain S, Riley P & Wallace DM () . Oncology Reports.
Hussain S () . Oncology Letters.
Hussain S, Palmer D, Swinson D, Riley P, Wills A, Brown C, Draycott C, El-Modir A, Peake D, Rea D , Chetiyawardana A et al () . Oncology Reports.
Okorie M, Hussain S, Riley P & McCafferty I () . Oncology Reports.
Choudhury A, Porta N, Hall E, Song YP, Owen R, MacKay R, West C, Lewis R, Hussain S, James N , Huddart R et al () Hypofractionated radiotherapy in invasive bladder cancer: an individual patient data meta‐analysis of the BC2001 and BCON trials. Lancet Oncology.

Chapters

Hussain S & James ND (2013) In Hussain S (Ed.), American Society Clinical Oncology Education Book
Hussain S & Palmer DH (2013) Systematic chemotherapy for liver tumours In Fong , Poon , Tang , Dupuy & Berlin (Ed.), Hepatobiliary Cancer
Hussain S, James ND, Bryan R, Patel P & Viney R (2012) Bladder cancer, in Perez and Brady's Principles and Practice of Radiation Oncology In Halperin EC, Wazer DE, Perez CA & Brady LW (Ed.), Percy and Brady textbook of radiation oncology
Hussain S, Zarkar A & James N (2008) Concomitant chemo-radiotherapy principles and management In Price (Ed.), Treatment of Cancer

Conference proceedings papers

Naqvi SAA, Saxena A, Faisal KS, Bibi A, Khan MA, Cobran EK, Hussain SA, Bin Riaz I, Bryce AH & Singh P (2024) Stratified absolute benefit with adjuvant immunotherapy (aIO) in muscle-invasive bladder cancer (MIBC): A meta-analysis. JOURNAL OF CLINICAL ONCOLOGY, Vol. 42(16)
Naqvi SAA, Faisal KS, Raina A, Khakwani KZR, Bin Riaz Z, Shah VS, Cobran EK, Singh P, Hussain SA, Bryce AH & Bin Riaz I (2024) Cost-effectiveness analysis of contemporary first-line (1L) agents in locally advanced/metastatic urothelial carcinoma (la/mUC). JOURNAL OF CLINICAL ONCOLOGY, Vol. 42(16)
Crabb SJ, Hussain SA, Oughton JB, Swain J, Cairns DA, Collinson M, Ainsworth G, McCready D, Griffin J, Heath P , Quayle L et al (2024) Use of gene expression patterns to identify unique molecular subtypes in muscle invasive bladder cancer: GUSTO. JOURNAL OF CLINICAL ONCOLOGY, Vol. 42(16)
Necchi A, Hussain SA, Loriot Y & de Velasco G (2024) SOGUG-NEOWIN: A Phase 2, open-label, multi-centre, multi-national interventional trial evaluating the efficacy and safety of Erdafitinib (ERDA) monotherapy and ERDA and Cetrelimab (CET) as neoadjuvant treatment in cisplatin-ineligible patients with Muscle-Invasive Bladder Cancer (MIBC) whose tumours express FGFR gene alterations. EUROPEAN UROLOGY, Vol. 85 (pp S427-S427)
Naqvi SAA, Bin Riaz I, He H, Imran M, Orme J, Childs DS, Ravi P, Hussain SA, Singh P & Bryce AH (2023) The role of volume of disease for treatment selection in patients with metastatic castration sensitive prostate cancer (mCSPC): A living meta-analysis. JOURNAL OF CLINICAL ONCOLOGY, Vol. 41(16)
Khetrapal P, Catto J, Ambler G, Williams N, Al-Hammouri T, Khan MS, Thurairaja R, Nair R, Nathan S, Sridhar A , Ahmad I et al (2023) MEASURING OBJECTIVE RECOVERY OF ACTIVITY LEVELS USING WEARABLE DEVICES FOLLOWING OPEN VS INTRACORPOREAL ROBOTIC CYSTECTOMY: SECONDARY OUTCOMES ANALYSIS OF THE IROC RANDOMIZED TRIAL. JOURNAL OF UROLOGY, Vol. 209 (pp E985-E985)
Ikram W, Naqvi SAA, Raina A, Fatima E, Siddiqi R, Islam M, Asghar N, Khakwani KZR, Khan AM, Hussain SA , Bryce AH et al (2022) Quantifying the absolute benefit of neoadjuvant chemotherapy followed by definitive therapy in patients with muscle-invasive bladder cancer: A systematic review and meta-analysis.. JOURNAL OF CLINICAL ONCOLOGY, Vol. 40(16)
Riaz IB, Naqvi SAA, He H, Asghar N, Siddiqi R, Khakwani KZR, Liu H, Hussain SA, Singh P, Murad M & Bryce AH (2022) Mixed treatment comparisons evaluating contemporary therapies in metastatic castration sensitive prostate cancer (mCSPC): A living systematic review. ANNALS OF ONCOLOGY, Vol. 33(7) (pp S1193-S1193)
Jones RJ, Hussain SA, Birtle AJ, Song YP, Enting D, Faust G, Hilman S, Jagdev S, McGovern UB, Parikh O , Lewis A et al (2022) A randomised, double blind, phase II clinical trial of maintenance cabozantinib following chemotherapy for metastatic urothelial carcinoma (mUC): Final analysis of the ATLANTIS cabozantinib comparison.. JOURNAL OF CLINICAL ONCOLOGY, Vol. 40(17)
Khetrapal P, Catto J, Ambler G, Ricciardi F, Khan S, Feber A, Dixon S, Williams N, Ahmed I, Charlesworth P , Cumberbatch M et al (2022) RESULTS OF THE INTRACORPOREAL ROBOTIC VS OPEN CYSTECTOMY (IROC) MULTI-CENTRE RANDOMISED TRIAL. JOURNAL OF UROLOGY, Vol. 207(5) (pp E695-E695)
Hussain SA, Lester JF, Jackson R, Gornall M, Elliott A, Crabb SJ, Huddart RA, Vasudev N, Birtle AJ, Worlding J , James ND et al (2020) Phase II randomized placebo-controlled neoadjuvant trial of nintedanib or placebo with gemcitabine and cisplatin in locally advanced muscle invasive bladder cancer (NEO-BLADE). JOURNAL OF CLINICAL ONCOLOGY, Vol. 38(6)
Andrews E, Curran C, Grivas P, Diamantopoulos LN, Drakaki A, Jain RK, Tandon A, Agarwal N, Tripathi A, Santos VS , Hussain SA et al (2020) Outcomes of advanced plasmacytoid urothelial carcinoma receiving systemic therapy. JOURNAL OF CLINICAL ONCOLOGY, Vol. 38(6)
James ND, Pirrie S, Liu W, Ford D, Zarkar A, Southgate E, Desai A & Hussain SA (2020) A phase I/II feasibility study of cetuximab with 5FU and mitomycin C or cisplatin with concurrent radiotherapy in muscle invasive bladder cancer. JOURNAL OF CLINICAL ONCOLOGY, Vol. 38(6)
Hussain SA (2019) Changing Landscape in the Management of Advanced Bladder Cancer. JOURNAL OF PATHOLOGY, Vol. 249 (pp S10-S10)
Porta N, Song YP, Hall E, Choudhury A, Owen R, Lewis R, Hussain S, James ND, Huddart RA & Hoskin P (2019) . International Journal of Radiation Oncology*Biology*Physics, Vol. 105(1) (pp S138-S138)
Van der Heijden M, Powles T, Petrylak D, de Wit R, Chi K, Necchi A, Sternberg CN, Matsubara N, Nishiyama H, Castellano D , Hussain S et al (2019) Biomarker analyses of ramucirumab in patients with platinum refractory urothelial cancer from RANGE, a global, randomized, double-blind, phase III study. ANNALS OF ONCOLOGY, Vol. 30
Jani VB, Patel A, Schurr J, Shell E, Bey J, Mitchell M, Shippey R, Kassab M, Razak A, Safdar A , Majid A et al (2016) Difference in Acute Ischemic Post Thrombolytic Stroke Outcomes in Pre Comprehensive and Post Comprehensive Status: Single Center Experience. STROKE, Vol. 47
Powles T, Wheater MJ, Din O, Geldart TR, Boleti E, Stockdale A, Sundar S, Robinson A, Ahmed I, Sarker S-J , Hussain SA et al (2015) . Journal of Clinical Oncology, Vol. 33(7_suppl) (pp 409-409)
James ND, Pirrie S, Barton D, Brown JE, Billingham L, Collins SI, Daunton A, Birtle AJ, Chakraborti PR, Ford D , Hussain SA et al (2013) Clinical outcomes in patients with castrate-refractory prostate cancer (CRPC) metastatic to bone randomized in the factorial TRAPEZE trial to docetaxel (D) with strontium-89 (Sr89), zoledronic acid (ZA), neither, or both (ISRCTN 12808747).. JOURNAL OF CLINICAL ONCOLOGY, Vol. 31(18)
James ND, Pirrie S, Barton D, Brown JE, Billingham L, Collins SI, Daunton A, Birtle AJ, Chakraborti PR, Ford D , Hussain SA et al (2013) Clinical outcomes in patients with castrate-refractory prostate cancer (CRPC) metastatic to bone randomized in the factorial trapeze trial to docetaxel (D) with strontium-89 (Sr89), zoledronic acid (ZA), neither, or both (ISRCTN 12808747).. JOURNAL OF CLINICAL ONCOLOGY, Vol. 31(15)

Posters

Khetrapal P, Catto J, Ambler G, Ricciardi F, Khan S, Feber A, Dixon S, Williams N, Ahmed I, Charlesworth P , Cumberbatch M et al (2022) PD42-02 RESULTS OF THE INTRACORPOREAL ROBOTIC VS OPEN CYSTECTOMY (IROC) MULTI-CENTRE RANDOMISED TRIAL.

Preprints

Jubber I, Morhardt DR, Griffin J, Cumberbatch M, Glover M, Zheng Y, Rehman I, Loynes C, Hussain SA, Renshaw SA , Leach SD et al (2023) , Cold Spring Harbor Laboratory.
Fulton B, Jones R, Powles T, Crabb S, Paul J, Birtle A, Chowdhury S, Hussain S, Morris A, Soulis E & Morrison P () , Research Square Platform LLC.
Fulton B, Jones R, Powles T, Crabb S, Paul J, Birtle A, Chowdhury S, Hussain S, Morris A, Soulis E & Morrison P () , Research Square Platform LLC.

Teaching interests

I regularly taught pharmacology to both undergraduate and postgraduate students in my previous roles and supervised both MSc and PhD students in both their projects and research. I am also:

Deputy Lead of Urology & Renal Phase 2a MBChB
Academic Lead for Medical Oncology Clinical Academic Training Programme.

Professional activities and memberships

Association of Cancer Physicians (ACP)
European Society of Medical Oncology (ESMO)
American Society of Clinical Oncology (ASCO)
NCRI Blader & Renal Clinical studies group
British Medical Association
Chair of the NCRI Advanced Bladder Cancer – subgroup